RxDoctor Payments Data

Anup Das

Hematology & Oncology · Wheeling, WVNPI 1790759082

Payments from drug & device makers

What this record shows

The money is spread across several categories — food and beverage (51.1%), consulting fees and education — rather than concentrated in one kind of arrangement. 27 manufacturers reported payments, led by Gilead at 43.7% of the total. Reporting peaked in 2020 at $1,454 and has fallen 88.8% since, to $163 in 2023.

$3,057in general payments, 2019–2025

Across 83 payments — averaging $36.83 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Gilead$1K
  • Johnson & Johnson$183
  • Merck$165
  • AstraZeneca$163
  • Novartis$156
  • Amgen$154
  • plus $899 from 21 others

What the payments were for

  • Consulting fees$1,30043%
  • Food & beverage$1,56151%
  • Education$1966%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
23

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,057 in reported general payments places this provider in the 65th percentile of 72 hematology & oncology providers in West Virginia.

See all hematology & oncology providers in West Virginia

Other hematology & oncology in Wheeling

See the full list for West Virginia

Where these figures come from

Is this you, or does something look wrong? →